Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Colorectal Neoplasms

Free Subscription 24.11.2025 1 Am J Epidemiol 2 Ann Surg Oncol 3 BMC Cancer 5 BMC Gastroenterol 2 Cancer Lett 3 Cancer Res 1 Dis Colon Rectum 2 Eur J Cancer 2 Eur J Surg Oncol 3 Gastrointest Endosc 5 Int J Colorectal Dis 1 Int J Oncol 2 J Am Coll Surg 1 J Clin Oncol 1 Lancet 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. BOTTA L, Capocaccia R, Bernasconi A, Rossi S, et al
   The impact of cancer survivors' extra risk of noncancer mortality on net survival estimation.
   Am J Epidemiol. 2025;194:3316-3324.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
   Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18696.
   PubMed         Abstract available
   
   
3. HOUBIERS A, Barbe R, Durand-Labrunie J, Bani MA, et al
   ASO Author Reflections: Future Role of Radiochemotherapy in the Multimodal Management of Retroperitoneal Lymph Node Metastases From Colorectal Cancer.
   Ann Surg Oncol. 2025 Nov 17. doi: 10.1245/s10434-025-18277.
   PubMed        
   
   

   
   BMC Cancer

4. SALGADO M, de la Camara-Gomez J, Garcia-Escobar I, Alvarez-Llosa RC, et al
   Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.
   BMC Cancer. 2025;25:1773.
   PubMed         Abstract available
   
   
5. MANSFIELD ME, Volpi CR, John C, Adebiyi R, et al
   Facilitator and barrier perspectives on learning and implementing high-resolution anoscopy in Abuja, Nigeria: a qualitative study.
   BMC Cancer. 2025;25:1766.
   PubMed         Abstract available
   
   
6. WU S, Zhang Y, Lin Z, Wei M, et al
   Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN.
   BMC Cancer. 2025;25:1770.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. ZHA B, Dou L, Liu Y, Zhang Y, et al
   Effect of endoscopic treatment for lesions in radiotherapy field after radiotherapy for rectal cancer.
   BMC Gastroenterol. 2025;25:812.
   PubMed         Abstract available
   
   
8. LI X, He Y, Yuan P, Ye Z, et al
   Association between the red cell distribution Width - coefficient of variation with colon cancer and all-cause mortality: insights from the 1999-2018 NHANES.
   BMC Gastroenterol. 2025;25:813.
   PubMed         Abstract available
   
   
9. YUE B, Lu Z, Zong D, Hu Y, et al
   Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021.
   BMC Gastroenterol. 2025;25:816.
   PubMed         Abstract available
   
   
10. WU KJ, Li JC, Liu LM, Huang XJ, et al
    Nitidine chloride inhibits colorectal cancer by targeting BUB1: mechanistic insights from molecular dynamics simulation, spatial transcriptomics, and single-cell RNA sequencing.
    BMC Gastroenterol. 2025;25:818.
    PubMed         Abstract available
    
    
11. DANIEL F, Hamieh N, Abdallah B, Hachicho F, et al
    Compliance and yield of follow-up colonoscopy after a positive FIT in real-life practice: a university hospital experience.
    BMC Gastroenterol. 2025;25:826.
    PubMed         Abstract available
    
    

    
    Cancer Lett

12. TAN S, Chen Y, Chen Y, Liu S, et al
    HOXC8-activated TRIM22/NF-kappaB Pathway Promotes Stemness in Colorectal Cancer.
    Cancer Lett. 2025 Nov 18:218156. doi: 10.1016/j.canlet.2025.218156.
    PubMed         Abstract available
    
    
13. TSAI YY, Chang HY, Hong WZ, Chen JY, et al
    Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer.
    Cancer Lett. 2025;637:218132.
    PubMed         Abstract available
    
    

    
    Cancer Res

14. GILLETTE A, Udgata S, Schmitz AE, Stoecker JN, et al
    Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.
    Cancer Res. 2025;85:4329-4340.
    PubMed         Abstract available
    
    
15. MOHAMMAD MIRZAEI N, Hur C, Terry MB, Dalerba P, et al
    Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the Impact of Population Screening.
    Cancer Res. 2025;85:4558-4570.
    PubMed         Abstract available
    
    
16. NATTRESS CB, O'Sullivan R, Fowler D, Hutton C, et al
    Phenoscaping Reveals Multimodal gammadelta T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation.
    Cancer Res. 2025;85:4415-4432.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

17. RADEMAKER E, Aktas BC, Snaebjornsson P, de Wilt JHW, et al
    Long-term Survival Outcomes of Synchronous Colon Cancer: A Cross-Sectional Population Based Comparative Analysis.
    Dis Colon Rectum. 2025 Nov 18. doi: 10.1097/DCR.0000000000004052.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

18. CERVANTES B, Grosnon C, Samaille T, Mas L, et al
    Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management.
    Eur J Cancer. 2025;232:116119.
    PubMed         Abstract available
    
    
19. WEISS L, Stintzing S, Modest DP, Stahler A, et al
    First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (
    Eur J Cancer. 2025;232:116105.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

20. LAU J, Ng A, Koh WL, Lee KY, et al
    The impact of colorectal cancer on quality of life of younger adults: A qualitative longitudinal approach.
    Eur J Surg Oncol. 2025;52:111169.
    PubMed         Abstract available
    
    
21. XIAO C, Zhang W, Qiu M, He D, et al
    A transformer-based pathomics model using endoscopic biopsy WSIs for predicting pathological complete response to preoperative immunotherapy in colorectal cancer.
    Eur J Surg Oncol. 2025;52:111182.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

22. VERHOEVEN DA, Basiliya K, van der Kraan J, Langers AMJ, et al
    Local recurrence rates of horizontal margin-positive en bloc endoscopic submucosal dissection of colorectal neoplasia: a meta-analysis.
    Gastrointest Endosc. 2025;102:799-810.
    PubMed         Abstract available
    
    
23. KWOK K, Chao C, Yan R, Attaluri V, et al
    EMR versus surgery for colon adenomas and early-stage cancers: a comparative effectiveness study.
    Gastrointest Endosc. 2025;102:890-893.
    PubMed         Abstract available
    
    
24. SHICHIJO S, Takeuchi Y, Kitagawa D, Ohkubo Y, et al
    Safety and feasibility of intensive endoscopic interventions for delayed perforation after colorectal endoscopic submucosal dissection (with video).
    Gastrointest Endosc. 2025;102:875-880.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

25. GUANA R, Soto Torselli AS, De Leo F, Marino B, et al
    Colorectal adenocarcinoma in children and adolescents: the management of advanced disease.
    Int J Colorectal Dis. 2025;40:237.
    PubMed         Abstract available
    
    
26. SHI A, Zheng J, Wu D, Yang X, et al
    Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system.
    Int J Colorectal Dis. 2025;40:236.
    PubMed         Abstract available
    
    
27. LOS B, Rocha BA, da Silva DN, Ribeiro VM, et al
    AI-driven pre-screening for colorectal cancer using complete blood counts: toward broader population impact.
    Int J Colorectal Dis. 2025;40:235.
    PubMed         Abstract available
    
    
28. CELIK CE, Chalabiyev E, Gurler V, Onur MR, et al
    Assessment of the correlation between visceral adiposity and liver fat in metastatic colorectal cancer patients.
    Int J Colorectal Dis. 2025;40:232.
    PubMed         Abstract available
    
    
29. ZHANG H, Yu S, Xiang J, Mongardini FM, et al
    Machine learning-based prediction model for omental metastasis in right-sided colon cancer patients: a retrospective multicenter study.
    Int J Colorectal Dis. 2025;40:233.
    PubMed         Abstract available
    
    

    
    Int J Oncol

30. SUN H, Pan Y, He B, Deng Q, et al
    [Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin?like growth factor 2 imprinting.
    Int J Oncol. 2026;68:7.
    PubMed         Abstract available
    
    

    
    J Am Coll Surg

31. EMILE SH, Wexner SD
    Discharge for Post-Acute Service After Colon Cancer Resection: A Healthcare Disparity.
    J Am Coll Surg. 2025 Nov 17. doi: 10.1097/XCS.0000000000001666.
    PubMed        
    
    
32. MYERS S, Chan WP, Davis ES, Murillo A, et al
    Allocation of Post-Acute Care Services Differs Among Rural and Urban Colon Cancer Patients After Resection.
    J Am Coll Surg. 2025 Nov 17. doi: 10.1097/XCS.0000000000001663.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

33. STAHLER A, Modest DP, Stintzing S, Borelli B, et al
    Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.
    J Clin Oncol. 2025 Nov 18:JCO2500596. doi: 10.1200/JCO-25-00596.
    PubMed         Abstract available
    
    

    
    Lancet

34. RASSCHAERT G, Tejpar S
    The dawn of immunotherapy in mismatch repair proficient colorectal cancer.
    Lancet. 2025;406:2302-2304.
    PubMed        
    
    

    
    PLoS One

35. TIAN Y, Zeng Y, Liu Y, Ye J, et al
    N-glycosylation of NANOG regulates stemness and apoptosis in colon cancer cells.
    PLoS One. 2025;20:e0336779.
    PubMed         Abstract available
    
    
36. INOUE A, Morimoto Y, Nishizawa Y, Hashimoto M, et al
    Clinical utility of circulating tumor DNA for early detection of recurrence after curative hepatectomy in patients with colorectal cancer with liver metastases: A prospective observational study protocol (CASSIOPEIA).
    PLoS One. 2025;20:e0335591.
    PubMed         Abstract available
    
    
37. ADRIANTO AA, Riwanto I, Sadhana U, Paramita DK, et al
    The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0307128.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. 
    Correction for Hao et al., Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2529649122.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.